Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Glioblastoma × niraparib × Clear all

Phase

Status

Active not recruiting 2 Withdrawn 1 Unknown 1 Terminated 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 11 Lung Neoplasms 2 Fallopian Tube Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Recurrent/ Advanced Stage Endometrial Cancer Patients 1 Platinum-resistant Ovarian Cancer 1 Pancreatic Neoplasms 1 Nausea 1 Mesothelioma, Malignant 1 Mesothelioma 1 Melanoma 1 Kenny-Caffey syndrome, Type 1 1 Glioblastoma 1 Endometrial Neoplasms 1 Cholangiocarcinoma 1 Breast Neoplasms 1

Interventions

Temozolomide 40 Radiotherapy 15 Bevacizumab 9 Surgical Procedures, Operative 5 Carmustine 5 pembrolizumab 3 Sunitinib 3 Radiation 3 Procarbazine 3 Lomustine 3 Irinotecan 3 Granulocyte-Macrophage Colony-Stimulating Factor 3 Chlorotoxin 3 Carboplatin 3 Blood Specimen Collection 3 fludarabine 2 camrelizumab 2 Radiosurgery 2 Neoadjuvant Therapy 2 Magnetic Resonance Spectroscopy 2 Hyperbaric Oxygenation 2 Ethanol 2 Drug Therapy 2 Cyclophosphamide 2 Chemotherapy, Adjuvant 2 CT-322 2 Bortezomib 2 Aminolevulinic Acid 2 verubulin 1 tislelizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04715620 2021-01-20

Niraparib Combined With Radiotherapy in rGBM

Tianjin Huanhu Hospital

Phase 2 Unknown

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡